Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |